M. Wittens

Lead-exposure associated miRNAs in humans and Alzheimer’s disease as potential biomarkers of the disease and disease processes

S. Engelborghs, I. Bergdahl, S. Kyrtopoulos, 2022, Scientific Reports.

Prognostic value of left ventricular global constructive work in patients with cardiac amyloidosis

T. de Ravel, M. Bjerke, R. Schots, 2022, The International Journal of Cardiovascular Imaging.

Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study

D. Smeets, B. Bergmans, H. Struyfs, 2021, Journal of Alzheimer's disease : JAD.

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

W. M. van der Flier, D. Rujescu, I. Giegling, 2022, Acta Neuropathologica.

iPSC-derived cortical neurons to study sporadic Alzheimer disease: a transcriptome comparison with post-mortem brain samples.

M. Nazaruk, F. Caiment, A. Sieben, 2021, Toxicology letters.

Inter- and Intra-Scanner Variability of Automated Brain Volumetry on Three Magnetic Resonance Imaging Systems in Alzheimer’s Disease and Controls

E. Fransén, D. Smeets, W. van Hecke, 2021, Frontiers in Aging Neuroscience.

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits

S. Engelborghs, C. Baeken, Wietse A. Wiels, 2021, Frontiers in Psychiatry.

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline

C. van Broeckhoven, S. Engelborghs, G. Nagels, 2021, Journal of Alzheimer's disease : JAD.